Lv5
950 积分 2023-08-29 加入
Gene editing for dyslipidemias: New tools to “cut” lipids
17天前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
25天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
1个月前
已完结
Lipoprotein(a) and cardiovascular disease
3个月前
已完结
Glycosylation Modification Balances the Aqueous Solubility of Lipidated Peptides and Facilitates Their Biostability
3个月前
已完结
Genetic studies on metabolic disorder associated kidney diseases
3个月前
已完结
Conjugation with glucagon like peptide-1 enables targeted protein degradation
3个月前
已完结
Intralesional or intraorbital rituximab injection for the management of biopsy-proven idiopathic orbital inflammation involving the lacrimal gland
4个月前
已完结
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease
5个月前
已完结
Ranibizumab Alters Levels of Intraocular Soluble Cytokine Receptors in Patients with Diabetic Macular Edema
6个月前
已完结
皖公网安备34019202002308
